Michael Surace, Ph.DDirector at AstraZeneca, USA
Agenda Sessions
Integrating the Reason for Spatial Heterogeneity in Cancers to Clinical Outcomes and Drug Development
, 08:05View Session
This site is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Integrating the Reason for Spatial Heterogeneity in Cancers to Clinical Outcomes and Drug Development